casipharmaceuticals.com (CASI) - Company Sales Volume

CASI Pharmaceuticals currently generates cash flow through the sale of certified oncology drugs in the PRC. Business growth is supported by partnerships with global biolabs to launch new hematological agents. The company's gross sales revenue confirms the effectiveness of its strategy, with the current level standing at 0.00. However, success depends on the speed of regulatory approvals and access to China's state medical insurance.

Revenue and Sales Volume: CASI Pharmaceuticals, Inc (CASI) for 07/04/2022 - 03/14/2026

Comprehensive metric breakdowns and analytics for CASI Pharmaceuticals Inc. (CASI)

- market price and analyst price targets:

Market Price CASI Pharmaceuticals, Inc|CASI - Analyst Consensus Forecast

- market capitalization indicators:

Market Capitalization CASI Pharmaceuticals, Inc.|CASI - Enterprise Value

- issuer book value statistics:

Accounting Value per Share CASI Pharmaceuticals|CASI - Book Capitalization|Market Capitalization to Book Value Ratio casipharmaceuticals.com|CASI - Aggregate Company Assets

- debt and solvency information:

Total Debt to Capital Coefficient CASI Pharmaceuticals|CASI - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient CASI Pharmaceuticals, Inc|CASI - Company Total Debt|Debt to Net Assets Ratio CASI Pharmaceuticals, Inc.|CASI - Company Long-Term Debt|Current Liabilities CASI Pharmaceuticals|Intermediate Coverage Ratio casipharmaceuticals.com

- company profitability and valuation multiples indicators:

CASI - Net Profit|Projected Future Earnings CASI Pharmaceuticals|CASI - Price to Earnings Ratio|Future Price to Earnings Multiple CASI Pharmaceuticals, Inc|CASI - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio CASI Pharmaceuticals, Inc.|CASI - Operating profit EBITDA|Net earnings per share (EPS TTM) CASI Pharmaceuticals|CASI - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months casipharmaceuticals.com|CASI - Earnings growth in current year|Expected net earnings per share growth next year CASI Pharmaceuticals

- company sales and revenue statistics:

CASI - Company Sales|Projected Sales Volume CASI Pharmaceuticals, Inc|CASI - Market Cap to Revenue|Price to Expected Revenue Ratio CASI Pharmaceuticals, Inc.

General company analysis:casipharmaceuticals.com - CASI

Manufactured product of casipharmaceuticals.com

The indicator's dynamics are based on the continuous monitoring of daily cash inflows, which eliminates time gaps in financial reporting. This metric captures the actual volume of product sales, reflecting the pace of business expansion or customer churn. For CASI Pharmaceuticals (CASI), this flow confirms market demand for innovative therapies for oncohematological diseases. By analyzing the company's commercial revenue, an investor assesses the balance between aggressive sales growth and brand resilience.

Analysis of competing companies